Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Stonestreet was diagnosed with type 2 diabetes in 2009, but kept it a secret. He told Business Insider why he's speaking out ...

Get your weekly dose of the top news that matters in our newsletter.

This simple, dietitian-designed week of meals ensures you’re getting all your essential nutrients while on a GLP-1 weight ...

Aon’s analysis found that while GLP-1 weight loss drugs increased costs initially, they lead to a reduction in long-term medical expenses due to fewer health issues.

As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.

(CNN) — Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after ...

The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and ...